Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy.

@article{Friess2001IncreasedGH,
  title={Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy.},
  author={Elisabeth Friess and Tania Kuempfel and Juliane Winkelmann and Diethart Schmid and M. Uhr and Rainer Rupprecht and Florian Holsboer and Claudia Trenkwalder},
  journal={Archives of neurology},
  year={2001},
  volume={58 2},
  pages={241-6}
}
BACKGROUND Parkinson disease (PD) is often difficult to distinguish from parkinsonian syndromes of other causes in early stages of the disease. In search of a suitable endocrinologic challenge test, we investigated dopaminergic sensitivity in patients with de novo parkinsonian syndromes. OBJECTIVE We measured the growth hormone (GH) response to a subthreshold dose of the dopamine 1-dopamine 2 receptor agonist apomorphine hydrochloride to differentiate parkinsonian syndromes from PD… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand

  • WW de Herder, AEM Reijs, DJ Kwekkeboom
  • Clin Endocrinol (Oxf)
  • 1996

Similar Papers

Loading similar papers…